Vimentin and N-cadherin are crucial markers of EMT transition in cancer cells [16] [17], and here we found a significant reduction in mRNA levels of Vimentin and N-Cadherin in both FDLT-treated NSCLC cell lines (Figure 6A,B). The gene discussed is VIM; the disease is cancer.